Lung Neuroendocrine Neoplasm
9 clinical trials · Condition
◉ Watch Lung Neuroendocrine Neoplasm
| Record | Firm | Date |
|---|---|---|
| A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM) (NCT04893785) | National Cancer Institute, Naples | 2021-06-15 |
| Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors (NCT03600233) | TaiRx, Inc. | 2018-12-15 |
| Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer (NCT03110978) | M.D. Anderson Cancer Center | 2017-06-26 |
| Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors (NCT02948946) | H. Lee Moffitt Cancer Center and Research Institute | 2017-01-09 |
| Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor (NCT01324492) | Novartis Pharmaceuticals | 2010-12-01 |
Track Lung Neuroendocrine Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.